Table 1 Tuberculosis patients in Israel, by HIV-infection status and co-infection risk, 1999-2011

Males

165 (65.0)

2837 (59.1)

0.04

1.2 (1.1-1.3

1.5 (0.6-3.8)

Time from arrival in Israel to TB diagnosis.

Median years (range)

5.5 (0–32)

6.0 (0–83)

0.001

0.8 (0.7-0.9)

0.8 (0.7-0.9)

Age group at TB diagnosis in years

18-24

13 (5.1)

453 (9.4)

0.01

0.2 (0.08-0.5)

0.4 (0.2-1.1)

25-34

85 (33.5)

1041 (21.7)

0.07 (0.03-0.1)

0.1 (0.05-0.3)

35-44

87 (34.3)

763 (15.9)

0.05 (0.02-0.1)

008 (0.04-0.2)

45-54

45 (17.7)

604 (12.6)

0.7 (0.03-1.2)

0.8 (0.1-1.3)

55-64

15 (5.9)

510 (10.6)

5.2 (2.3-12.2)

3.2 (2.1-8.6)

>65

8 (3.1)

1436 (29.8)

1

Israeli citizens

198 (78.3)

3886 (81.0)

<0.001

1.2 (0.9-1.6)

Country/area of birth

Israel

11 (4.3)

604 (12.6)

<0.001

1

Ethiopia

137 (54.1)

858 (17.9)

4.6 (1.4-15.3)

6.5 (1.6-25.5)

Horn of Africa

15 (5.9)

192 (4.0)

0.3 (0.1-0.6)

0.8 (0.6-1.7)

Former Soviet Union

50 (19.8)

1629 (34.0)

0.3 (0.1-0.8)

0.3 (0.2-0.6)

Europe

4 (1.6)

320 (6.7)

1.7 (0.5-6.4)

1.9 (0.8-2.5)

South east Asia

6 (2.4)

461 (9.6)

1.2 (0.5-3.5)

1.1 (0.3-3.3)

Others

31 (12.2)

733 (15.3)

1.8 (0.7-2.1)

1.3 (0.9-1.7)

Positive culture

211 (83.4)

3612 (75.3)

<0.001

1.5 (1.12-2.2)

1.9 (1.3-3.0)

Multi drug resistance

19 (7.5)

189 (3.9)

0.007

1.9 (1.2-3.1)

1.9 (1.1-3.3)

Pulmonary TB

203 (80.2)

3876 (80.8)

0.7

1.1 (0.7-1.4)

Treatment success*

179 (70.8)

3953 (82.4)

<0.001

Died during treatment

43 (17.0)

492 (10.3)

<0.001